NVWM LLC’s Cocrystal Pharma COCP Stock Holding History

NVWM LLC’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88	Hold	84	–	–	﹤0.01%	750
2026 Q1	$85	Hold	84	–	–	﹤0.01%	717
2025 Q4	$82	Hold	84	–	–	﹤0.01%	722
2025 Q3	$105	Hold	84	–	–	﹤0.01%	662
2025 Q2	$125	Hold	84	–	–	﹤0.01%	659
2025 Q1	$119	Hold	84	–	–	﹤0.01%	637
2024 Q4	$170	Hold	84	–	–	﹤0.01%	627
2024 Q3	$148	Hold	84	–	–	﹤0.01%	623
2024 Q2	$196	Hold	84	–	–	﹤0.01%	596
2024 Q1	$118	Hold	84	–	–	﹤0.01%	588
2023 Q4	$145	Hold	84	–	–	﹤0.01%	391
2023 Q3	$157	Hold	84	–	–	﹤0.01%	416
2023 Q2	$201	Hold	84	–	–	﹤0.01%	442
2023 Q1	$167	Hold	84	–	–	﹤0.01%	425
2022 Q4	$164	Buy	84 +1	+1%	+$3	﹤0.01%	419
2022 Q3	$0	Hold	83	–	–	﹤0.01%	443
2022 Q2	$0	Hold	83	–	–	﹤0.01%	477
2022 Q1	$1K	Hold	83	–	–	﹤0.01%	509
2021 Q4	$1K	Hold	83	–	–	﹤0.01%	483
2021 Q3	$1K	Hold	83	–	–	﹤0.01%	480
2021 Q2	$1K	Buy	+83	New	+$1.26K	﹤0.01%	422

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

NVWM LLC's COCP Position: Q2 2026 in Review

NVWM LLC held its Cocrystal Pharma (COCP) position steady in Q2 2026 at 84 shares worth $88. The position accounts for ﹤0.01% of the portfolio, ranked #750.

NVWM LLC first reported a position in COCP in Q2 2021 and has held it in 21 quarters since. The position peaked at $1K in Q1 2022. 19 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

NVWM LLC held 84 shares of Cocrystal Pharma worth $88 as of Q2 2026.
NVWM LLC left its Cocrystal Pharma share count unchanged in Q2 2026.
Cocrystal Pharma made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #750 holding.
NVWM LLC first reported a position in Cocrystal Pharma in Q2 2021 and has held it in 21 quarters since.
NVWM LLC's Cocrystal Pharma position peaked at $1K in Q1 2022.
19 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.